CARL
CARLSMED, INC.Company Information
- Company Name
- CARLSMED, INC.
- CIK
- CIK0001794546
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CARL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- CARL
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-07-24
- Last sale
- 2026-03-02
- Shares purchased (TTM)
- 3,406,664
- Shares sold (TTM)
- 197,855
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 5,765,942
- Shares outstanding
- 27,190,765
- Ownership
- 21.21%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 24.48%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||
| Cash And Cash Equivalents At Carrying Value | 46 | 73 | 86 | 115 | 33 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Investments | 24 | 24 | 24 | - | - | ||||||
| Accounts Receivable Net Current | 14 | 12 | 11 | 11 | 10 | ||||||
| Inventory Net | 2 | 2 | 2 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 3 | 2 | ||||||
| Assets Current | 110 | 115 | 127 | 131 | 46 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 6 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 4 | ||||||
| Assets | 118 | 119 | 130 | 135 | 53 | ||||||
Liabilities Current | |||||||||||
| Accounts Payable Current | 4 | 3 | 4 | 3 | 3 | ||||||
| Accrued Liabilities Current | 4 | 3 | 3 | 3 | 3 | ||||||
| Accrued Employee Benefits Current | 4 | 3 | 6 | 4 | 3 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 12 | 10 | 14 | 11 | 9 | ||||||
| Long Term Debt | 15 | 15 | 15 | 15 | 15 | ||||||
| Operating Lease Liability Noncurrent | 6 | 1 | 1 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 34 | 27 | 31 | 28 | 28 | ||||||
Stockholders Equity | |||||||||||
| Preferred Stock Value | 0 | - | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 204 | 202 | 200 | 199 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -120 | -110 | -101 | -92 | -84 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | - | - | - | - | ||||||
| Stockholders Equity | 84 | 92 | 99 | 107 | -83 | ||||||
| Liabilities And Stockholders Equity | 118 | 119 | 130 | 135 | 53 | ||||||
| Series A Convertible Preferred Stock | - | - | 0 | -5 | 0 | ||||||
| Series B Convertible Preferred Stock | - | - | 0 | -4 | 0 | ||||||
| Series C Convertible Preferred Stock | - | - | 0 | -6 | 0 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 3 | 2 | 2 | - | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 24 | ||||||
| Common Stock Shares Issued | 27 | 27 | 27 | 27 | 5 | ||||||
| Shares Outstanding | 27 | 27 | 27 | 27 | 5 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCARLSMED, INC. (CARL) — SEC Financial Statements & Analysis
CARLSMED, INC. (CARL) is a surgical & medical instruments & apparatus company, incorporated in DE. CARLSMED, INC. trades on Nasdaq as: CARL. CARLSMED, INC. (CARL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, CARLSMED, INC. carries a market cap of $282.24M, a P/E ratio of -6.71x, a P/B ratio of 3.35x, a P/S ratio of 3.84x, an enterprise value of $251.38M, and an EV/EBITDA multiple of -5.72x. On profitability, it posts a gross margin of 76.39%, an operating margin of -60.40%, a net margin of -57.26%, a Return on Equity (ROE) of -7173.74%, a Return on Assets (ROA) of -49.07%, and a Return on Invested Capital (ROIC) of -110.91%. Per share, it reports EPS of $-1.55, diluted EPS of $-1.55, free cash flow per share of $-1.27, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 8.84x, a quick ratio of 8.32x, working capital of $97.20M, a debt-to-equity ratio of 0.40x, a debt ratio of 0.29, an interest coverage ratio of -26.25x, free cash flow of $-34.58M (TTM), and net debt of $-30.86M. Figures sourced from SEC EDGAR.
- Market Cap
- $282.24M
- P/E TTM
- -6.71x
- EPS TTM
- $-1.55
- P/B TTM
- 3.35x
- ROE TTM
- -7173.74%
- ROA TTM
- -49.07%
- Debt To Equity
- 0.40x
- Free Cash Flow TTM
- $-34.58M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CARLSMED, INC. in?
CARLSMED, INC. (CARL) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does CARL trade on?
CARLSMED, INC. (CARL) trades on the Nasdaq.
Where is CARLSMED, INC. incorporated?
CARLSMED, INC. is incorporated in DE.
When was CARLSMED, INC. (CARL)'s most recent SEC filing?
CARLSMED, INC. (CARL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is CARL's market cap?
CARLSMED, INC. (CARL) has a market capitalization of $282.24M as of 2026-06-30.
What is CARL's EPS (earnings per share)?
CARLSMED, INC. (CARL)'s trailing twelve month EPS is $-1.55 as of 2026-06-30.
What is CARL's ROE (return on equity)?
CARLSMED, INC. (CARL)'s trailing twelve month Return on Equity (ROE) is -7173.74% as of 2026-06-30.
What is CARL's ROA (return on assets)?
CARLSMED, INC. (CARL)'s trailing twelve month Return on Assets (ROA) is -49.07% as of 2026-06-30.
What is CARL's ROIC (return on invested capital)?
CARLSMED, INC. (CARL)'s trailing twelve month Return on Invested Capital (ROIC) is -110.91% as of 2026-03-31.
What is CARL's EV/EBITDA?
CARLSMED, INC. (CARL)'s trailing twelve month EV/EBITDA is -5.72x as of 2026-06-30.